CD8A and non-small cell lung carcinoma: And exosomal circUSP7 derived from NSCLC cells targets the miR‐934/SHP2 axis, causing CD8+ T cell dysfunction and increasing resistance to anti‐PD1 therapy in NSCLC patients.194